Dr. Christin Glorioso
Christin Glorioso, MD, Ph.D., is the CEO and Cofounder of NeuroAge Therapeutics and the Founder and Executive Director of Longevity Global. She is an Epidemiologist, Physician-Scientist, and Serial Entrepreneur with expertise in Neuroscience, AI, and Computational Modeling.
Christin has more than 20 years of research experience pioneering aging clocks in the human brain, which forms the basis of her longevity tech-bio startup, NeuroAge Therapeutics. NeuroAge is a winner of the US National Institute on Aging Startup Challenge 2022, a recipient of an Illumina sequencing grant, winner of an MBC BioLabs Golden Ticket, and was named one of the top 10 companies to watch in 2023 by Life Science Nation.
She is the Founder and Executive Director of the nonprofit, Longevity Global, which connects longevity researchers, investors, and entrepreneurs in the SF Bay Area, NYC, San Juan, and the UAE.
During the pandemic, Christin became heavily involved with nonprofit efforts at providing predictions, resources, and information globally for COVID-19. She had the #1 US COVID-19 cases predictive model out of 104 global teams in the XPRIZE Pandemic Response Challenge.
Her model had a 7% error for an eight week out prediction, which is more accurate and for a longer time window than any of the US CDC models. Read What Herd Immunity actually is (hint: it’s not what you think) and why it’s a good reason to be more careful and Privacy preserving crowdsourcing for citizen engagement in pandemics.
As the Head of Research at the Data Informatics Center for Epidemiology at the PathCheck Foundation in 2021, she used her model to create predictions for the Karuna App, which provided live oxygen leads using Twitter scraping during the Delta COVID wave in India and had 23 million users.
This led her to organizing a group of 20 volunteers from 7 countries, the Global Health Research Collective, which published 6 papers and created a COVID risk calculator app. Read Researchers built dozens of COVID-19 forecasting models — did they actually help? and Accuracy of US CDC COVID-19 forecasting models.
Previously, between 2021 and 2022, Christin was Chief Strategist of UCSF’s Bakar Aging Research Institute and also the Head of AI at TeachAids. TeachAids is a nonprofit organization formed at Stanford University that brings health education materials to more than 82 countries for free.
As Head of AI of the COVIDB initiative, Christin was leading a team fighting against misinformation by disseminating reliable COVID-19 news using AI and ML. She is also a Member of CoronaSurveys, a collaborative project and endeavor between several universities, research institutions, and independent volunteers. Data about the COVID-19 pandemic has been collected by this project since March 2020 via anonymous open surveys. This data allows the production of estimates on the incidence and evolution of COVID-19 using the Network Scale-up Method.
Christin earned her Bachelor’s Degree of Science in Cell and Molecular Biology in 2002 from the University of Michigan. In 2003, she became a Medical Student and started her Medical Scientist Training Program (MSTP) at the University of Pittsburg, School of Medicine. She earned her MD and Ph.D. in Neuroscience in 2011 with her thesis Between destiny and disease: genetics and molecular pathways of CNS aging from Carnegie Mellon Medical Scientist Training Program and the University of Pittsburgh.
After her Doctorate, between 2012 and 2017, Christin became Postdoctoral Associate in Computational Biology at MIT, where she was studying Brain Aging and Neurological Disease in the Laboratory of Dr. Lenny Guarente in the Department of Biology. In 2013, she also Cofounded the MIT Think Tank.
In 2017, she became Research Scientist at MIT, where she worked on Predictive Modeling, Genetics, Epigenetics, and Transcriptomics of Neurological/Psychiatric diseases and brain aging rates in large living and post-mortem human cohorts.
Since 2013, Christin has been the CEO and Cofounder of Academics for the Future of Science Incorporated. AFS is a 501(c)(3) nonprofit science advocacy and research organization started by early-career scientists at MIT. They promote science advocacy and literacy including leading grass roots efforts to increase the US federal science budget. They are a partner of the March for Science.
Christin was also a Lecturer at MIT, Boston University, and the NY Institute of Technology. She occasionally teaches COVID-19 epidemiology for physician Continuing Medical Education (CME) and at nursing schools.
Christin is an On Deck Longevity Biotech Fellow, recipient of the MIT Infinite Mile Award for Community Building, AFAR Postdoctoral Fellowship Award, Glenn Foundation for Medical Research Fellowship, and NIA F30 MD/PhD training award.
Read The Impact of Scientific Advisory Boards on Longevity Biotech Startups: Opportunities and Challenges.
Watch Longevity Series Lecture: Brain Aging | Christin Glorioso, MD, PhD, Dr. Christin Glorioso — “Reprogramming Brain Aging to Treat Dementia”, and Achieving Brain Longevity, Metformin Fears, & Alzheimers Drama with Christin Glorioso.
Visit her LinkedIn profile, ResearchGate profile, and Google Scholar page. Follow her on Facebook, Substack, F6S, Clay, GitHub, ORCiD, YouTube, and Twitter.
